Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: Jay Fisk who wrote (67268)	2/20/2001 1:25:37 AM
From: StockDung	Respond to of 122087

Its a fraud. A big penny fraud. James Kosta was also a director of Infotopia which stockpatrol.com wrote 5 articles about. Look at informedinvestor.com . What a sham on the public these guys are. At insidetruth.com we name names Strategic Communications (STRCOMM-DOM) 5190 Neil Road, Suite 215 Reno, NV 89502 US Domain Name: strcomm.com Administrative Contact, Technical Contact, Billing Contact: Pierce, Robert (RP15358) rpierce@RPIERCEDESIGN.COM P.O. Box 18642 Reno, NV 89511-0642 775-327-6148 (FAX) 509-693-2896 Record last updated on 13-Sep-2000. Record expires on 18-Apr-2001. Record created on 18-Apr-2000. Database last updated on 19-Feb-2001 10:23:07 EST. Domain servers in listed order: DNS1.KOSTECH.COM 207.228.56.5 NS1.GREATBASIN.NET 207.228.35.42 NS2.GREATBASIN.NET 207.228.37.195 Kostech Corporation (INFORMEDINVESTOR2-DOM) 5190 Neil Rd Suite 401 Reno, NV 89502 US Domain Name: informedinvestor.com Administrative Contact, Technical Contact, Billing Contact: Kosta, James (JK3154) jkosta@KOSTECH.COM Kostech Corporation 5190 Neil Rd. Suite 401 Reno, NV 89502 702-827-8781 (FAX) 702-827-9024 Record last updated on 28-Nov-2000. Record expires on 07-Aug-2001. Record created on 07-Aug-1998. Database last updated on 19-Feb-2001 10:19:04 EST. Domain servers in listed order: DNS1.KOSTECH.COM 207.228.56.5 NS1.GREATBASIN.NET 207.228.35.42 NS2.GREATBASIN.NET 207.228.37.195

To: Jay Fisk who wrote (67268)	2/20/2001 1:30:08 AM
From: StockDung	Respond to of 122087

Detailed Product Description invest.iveshealth.com T-Factor The Java Project Read about the Landmark AIDS Study that started it all! An AIDS Treatment Breakthrough! T-Factor® is a patent-pending hormonal inhibitor for patients infected with the HIV/AIDS virus and Hepatitis. Although designed primarily for those with HIV/AIDS and Hepatitis, T-Factor® will also benefit those suffering from ANY auto-immune diseases or deficiencies. T-Factor tablets offer many benefits such as: Increased T-Cell count Decreased viral load Can be taken in conjunction with other medications Nil side effect profile Affordable and accessible All natural ingredients Decreases opportunistic illnesses and infections due to improved Immune System function Dr. Robert Slayton-Bedeen, who has been involved in immunological research for the last decade, conducted a study called the Java Project in association with the World Health Organization and its global program on AIDS. The Java Project studied 186 patients who were infected with the HIV/AIDS virus. Both asymptomatic and symptomatic men and women demonstrated improved health and were 3 times less likely to progress to AIDS. Increased CD-4 cell counts persisted for up to 78 weeks. Regimes were well tolerated, with nil side effect profile. Changes in CD-4 cell counts began 12 weeks into treatment. The treatment is now the patent pending formula known as T-Factor®. While T-Factor® is not a cure, it decreases the risk for opportunistic diseases that plague the HIV/AIDS population—thus providing hope for a better quality of life. Add this item to your Shopping Cart!